Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2156279 | 0.93 | CYP2D6 (0.34) | KDM4ETSHRHSD17B10CDK1MAPT | |
| SCHEMBL2156720 | 0.90 | KDM4E (0.37) | KDM4ETSHRHSD17B10MAPTSMN1; SMN2 | |
| SCHEMBL2157334 | 0.83 | ALDH1A1 (0.35) | KDM4ETSHRHSD17B10CDK1MAPT | |
| SCHEMBL2162790 | 0.82 | KDM4E (0.32) | KDM4ETSHRHSD17B10CDK1SMN1; SMN2 | |
| SCHEMBL2996273 | 0.80 | SCN9A (0.38) | KDM4ETSHRHSD17B10CYP2D6 | |
| SCHEMBL2157499 | 0.80 | KDM4E (0.34) | KDM4ETSHRHSD17B10MAPTSMN1; SMN2 | |
| SCHEMBL2157396 | 0.80 | NR1I3 (0.34) | KDM4E | |
| SCHEMBL2998707 | 0.80 | KDM4E (0.36) | KDM4EMAPTSMN1; SMN2KMT2A | |
| SCHEMBL2156465 | 0.79 | KDM4E (0.34) | KDM4ETSHRHSD17B10KMT2A | |
| SCHEMBL3095427 | 0.79 | PRKCA (0.38) | KDM4ESMN1; SMN2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7973026-B2 | Thienopyrroles as antiviral agents | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2011-07-05 | — | — | US | disclosed |
| US-20090105227-A1 | Thienopyrroles As Antiviral Agents | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105227-A1 | Thienopyrroles As Antiviral Agents | ZC3HAV1, HAVCR2, ZC3HAV1L | KDM4E 3275/4885TSHR 118/4885HSD17B10 2452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.